Mural Oncology (NASDAQ:MURA – Get Free Report)‘s stock had its “hold” rating restated by equities researchers at Jones Trading in a note issued to investors on Tuesday,Benzinga reports.

On Tuesday, Jones Trading revised its rating for Mural Oncology (NASDAQ: MURA) stock, downgrading it from Buy to Hold following a recent development in the company’s clinical trials. According to ...

Founded in 1969 by Nigel Jackson and Patricia Grey, Acts of Art exemplified the spirit of a subversive and consequential period in Black art history.

Mural Oncology said that it won't continue developing its ovarian cancer drug candidate Nemvaleukin to be used in conjunction with Merck's Keytruda after results showed no statistical improvement ...

From L.A. to New York and everywhere in between, see what your favorite stars are up to Toria Sheffield joined the PEOPLE editorial staff in 2024. Her work as a writer/editor has previously ...

Alex Jones has issued a significant announcement ... after she moved house after 11 years and then got a new Labrador dog named Scout. The 48-year-old Welsh star currently shares three children ...

Officials with the Iowa Department of Agriculture and Land Stewardship are also seeking to destroy 1,930 pounds of meat ...

Planning a family vacation with teens can be a challenge, but we’ve got you covered. Our curated list of the best ...